For Sleep Disturbance in Alzheimer Disease, Cannabinoid-Based IGC-AD1 Shines in Phase 2
Depression, Anxiety Underrecognized and Undertreated in COPD, Increasing Disease Burden
A new analysis reveals significant gaps in diagnosis of and treatment for psychiatric disorders in adults with COPD and calls for larger, longitudinal studies.
Better CV Health Tied to Lower Neurodegeneration Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Underutilization of Guideline-Recommended Epinephrine in Anaphylaxis Management: New Study
A 5-year study conducted in Germany showed only 7% of adults and 8% of children with severe anaphylaxis received epinephrine.
UK Research Collaborative Will Evaluate GSK Shingles Vaccine Effect on Dementia
GSK is partnering with the UK Dementia Research Institute and Health Data Research UK to further investigate the potential for the RZV vaccine to mitigate cognitive decline.
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation
The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.
Long COVID's Long Road: A Year 5 Update with Noah Greenspan DPT, PT, CCS, EMT-B
Five years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.
Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet
Data from the phase 2 VENTURE-Oral Dosing Trial of VK2735 is expected in the second half of the year, the company said.
Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose
Eisai Will Highlight Real-World Experience Data with Lecanemab at 2025 American Academy of Neurology Meeting
Data on use of lecanemab in real world clinical settings will come from a neurologic case series review and a retrospective chart review of long-term use, both in early AD.
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
Nearly Half of Adults Diagnosed with MDD May Have Treatment Resistant Depression, Many Feel Hopeless
More than one-third of study participants with TRD had failed to get relief from 4 or more antidepressants, calling treatment experiences a "trial and error" process.
Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US
ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.
America Leads High-Income Countries for Avoidable Deaths
Rates of preventable deaths are rising in every US state, according to a new study, defying the country's top-ranking spending on health care.
OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose
Does it Itch? Is it Painful? Is it Dry? Dermatoses Symptoms Don't Lie
Raj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.
Deadline Intervention Boosts Colorectal Cancer Screening Uptake: New Study
Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates, according to new research.
More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal
For the same level of baseline health, the increase in risk related to each of 8 key CV risk factors appears significantly higher in women than in men.
Omlyclo Gains FDA Approval as Interchangeable Omalizumab Biosimilar: Daily Dose
Initial Treatment with Dual Statin + Ezetimibe Cuts All-Cause Mortality by 50%: New Meta-Analysis
The reductions observed in all-cause mortality (49%) and MACE (39%) in high-risk patients compared with statin monotherapy could be practice changing, researchers said.
